Deltec Asset Management’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Deltec Asset Management’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,367	Closed	-$12K	–	202
2019 Q3	$12K	Buy	20,367 +9,831	+93%	+$5.48K	﹤0.01%	164
2019 Q2	$7K	Hold	10,536	–	–	﹤0.01%	159
2019 Q1	$12K	Sell	10,536 -49,764	-83%	-$48.7K	﹤0.01%	161
2018 Q4	$27K	Hold	60,300	–	–	0.01%	150
2018 Q3	$96K	Sell	60,300 -43,346	-42%	-$57.6K	0.02%	167
2018 Q2	$38K	Buy	+103,646	New	+$31.2K	0.01%	172
2013 Q4	–	Sell	-50,300	Closed	-$404K	–	164
2013 Q3	$404K	Hold	50,300	–	–	0.11%	99
2013 Q2	$368K	Buy	+50,300	New	+$365K	0.11%	104

Deltec Asset Management's CELGZ Position: Q4 2019 in Review

Deltec Asset Management sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 20,367 shares — an estimated $12K sold.

Deltec Asset Management first reported a position in CELGZ in Q2 2013 and held it in 8 quarters. The position peaked at $404K in Q3 2013. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.

Deltec Asset Management reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
Deltec Asset Management sold 20,367 Celgene Corporation Contingent Value Rights shares in Q4 2019, an estimated $12K.
Deltec Asset Management first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and held it in 8 quarters.
Deltec Asset Management's Celgene Corporation Contingent Value Rights position peaked at $404K in Q3 2013.
0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.

Based on Deltec Asset Management's 13F filing for Q4 2019, filed 27 Jan 2020.